Evidence that antipsychotic drugs are inverse agonists at D-2 dopamine receptors

Hall, David A. and Strange, Philip G. (1997) Evidence that antipsychotic drugs are inverse agonists at D-2 dopamine receptors. British Journal of Pharmacology, 121 (4). pp. 731-736. ISSN 0007-1188. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1038/sj.bjp.0701196

Abstract

1 The effects of a number of D-2-like dopamine receptor antagonists have been determined on forskolin-stimulated cyclic AMP accumulation in Chinese hamster ovary (CHO) cells expressing the human D-2short dopamine receptor (CHO-D2S cells). 2 Dopamine inhibited the effect of forskolin (as expected for a D-2 receptor). However, all of the antagonists tested, apart from UH232 and (-)-butaclamol, were able to increase cyclic AMP accumulation above the forskolin control level. (+)-Butaclamol elicited a similar stimulation of forskolin-stimulated cyclic AMP accumulation in a CHO cell line expressing human D-2long dopamine receptors whereas it exhibited no stimulating effect on forskolin-stimulated cyclic AMP accumulation in untransfected CHO-K1 cells. 3 There was a strong correlation between the EC50 values of these compounds for potentiation of cyclic AMP accumulation and their K-i values from radioligand binding experiments in CHO-D2S cells. 4 The effects of both (+)-butaclamol and dopamine in CHO-D2S cells were inhibited by pre-treatment with pertussis toxin indicating a role for Gi/Go proteins. 5 UH232 did not significantly affect forskolin-stimulated cyclic AMP accumulation but this substance was able to inhibit the effects of both dopamine and (+)-butaclamol in a concentration-dependent manner. Thus the effects of (+)-butaclamol on forskolin-stimulated cyclic AMP accumulation an mediated directly via the D-2 receptor rather than by reversal of the effects of an endogenous agonist. 6 These data suggest that the D-2 dopamine receptor antagonists tested here, many of which are used clinically as antipsychotic drugs, are in fact inverse agonists at human D-2 dopamine receptors.

Item Type: Article
Uncontrolled keywords: inverse agonism; dopamine receptors; antipsychotic drugs
Subjects: R Medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculties > Science Technology and Medical Studies > School of Biosciences
Depositing User: M.A. Ziai
Date Deposited: 23 Jul 2009 17:37
Last Modified: 16 Apr 2014 15:45
Resource URI: https://kar.kent.ac.uk/id/eprint/18092 (The current URI for this page, for reference purposes)
  • Depositors only (login required):